CClinicalTrials.gg
Sign In
Status unknownNCT04896762Updated Oct 25, 2022

Extrapulmonary Presentations of COVID-19 Patients

An observational study in COVID-19, sponsored by Sohag University. Status unknown at 1 site in Egypt. Per ClinicalTrials.gov, last updated 2022-10-25.

Sponsored by Sohag University · Observational

The sponsor has not verified this record recently (last verified Oct 2022), so the status shown — last known as Active, not recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
948
Sex
All
01

Study summary

An observational study about the extrapulmonary presentations of COVID-19 patients during the second wave of the pandemic.

Read the detailed description

a prospective observational study that aimed at

  1. provide an overview about the prevalence of extra-pulmonary presentation of COVID-19 during the second wave of the pandemic and
  2. Detection of the most frequent affected systems with comparison between the pulmonary and extrapulmonary presentation of COVID 19 as regard patient demographics, comorbidity and level of care needed.
02

Conditions studied

  • COVID-19

Browse trials for

Keywords

  • extrapulmonary presentation
  • pulmonary
03

In context

COVID-19

7,641 studies on the registry are indexed under COVID-19; 487 are open to participants now.

This study's enrollment of 948 is above the median of 261 across 3,136 observational studies indexed under COVID-19.

Browse COVID-19 studies →

Lead sponsor

Sohag University is the lead sponsor of 1,183 studies on the registry; 612 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

patients presented at a triage point in a tertiary health care facility with a suspected covid 19 disease.

Inclusion criteria

  • all patient with confirmed covid 19 disease presented to our health facility during the second wave of the pandemic

Exclusion criteria

Exclusion Criteria:

  • other diagnosis than covid 19 as a primary cause of presentation of the patient
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
948 participants (actual)
Patient registry
No

Groups and cohorts

  • Extrapulmonary presentation for COVID-19

    patients with confirmed covid 19 disease who primarily presented with extrapulmonary system affection

  • pulmonary presentation for COVID-19

    patients with confirmed covid 19 disease who primarily presented with pulmonary disease

06

What researchers measure

Primary outcomes

  1. extrapulmonary presentation in COVID-19

    frequency of extrapulmonary presentation inCOVID-19 second wave pandemic

    Time frame: Baseline presentation of confirmed cases with COVID-19

07

Study locations

1 site
  • Sohag University
    Sohag, 82425, Egypt
08

References and documents

Publications

  • Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. 2020 May;20(5):533-534. doi: 10.1016/S1473-3099(20)30120-1. Epub 2020 Feb 19. No abstract available. Erratum In: Lancet Infect Dis. 2020 Sep;20(9):e215. doi: 10.1016/S1473-3099(20)30509-0. PubMed 32087114 ↗
  • Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24. Erratum In: Lancet. 2020 Feb 15;395(10223):496. doi: 10.1016/S0140-6736(20)30252-X. PubMed 31986264 ↗
  • Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC, Du B, Li LJ, Zeng G, Yuen KY, Chen RC, Tang CL, Wang T, Chen PY, Xiang J, Li SY, Wang JL, Liang ZJ, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Zhong NS; China Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28. PubMed 32109013 ↗

Individual participant data

Plan to share: Undecided

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 25, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04896762
Lead sponsor
Sohag University
Responsible party
Hend Mohammed Abdelraheem Esmaeel (assistant professor, Sohag University) — Principal investigator
First posted
May 21, 2021
Start date
Sep 1, 2020
Primary completion
Dec 31, 2021
Completion
Dec 2022 (estimated)
Last update
Oct 25, 2022

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Oct 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

COVID-19→

Other studies from this sponsor

Sohag University

Start the discussion